Nicotine receptor partial agonists for smoking cessation

K Cahill, N Lindson‐Hawley… - Cochrane database …, 2016 - cochranelibrary.com
Background Nicotine receptor partial agonists may help people to stop smoking by a
combination of maintaining moderate levels of dopamine to counteract withdrawal …

Emerging evidence for cannabis' role in opioid use disorder

B Wiese, AR Wilson-Poe - Cannabis and cannabinoid research, 2018 - liebertpub.com
Introduction: The opioid epidemic has become an immense problem in North America, and
despite decades of research on the most effective means to treat opioid use disorder (OUD) …

[HTML][HTML] Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs

E Dale, B Bang-Andersen, C Sánchez - Biochemical pharmacology, 2015 - Elsevier
The monoamine hypothesis has been the prevailing hypothesis of depression over the last
several decades. It states that depression is associated with reduced monoamine function …

DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome

A Duchon, Y Herault - Frontiers in behavioral neuroscience, 2016 - frontiersin.org
Down syndrome (DS) is one of the leading causes of intellectual disability, and patients with
DS face various health issues, including learning and memory deficits, congenital heart …

[HTML][HTML] The analysis of acne increasing suicide risk

S Xu, Y Zhu, H Hu, X Liu, L Li, B Yang, W Wu, Z Liang… - Medicine, 2021 - journals.lww.com
Acne is associated with depression and anxiety; however, the relationship between acne
and suicide is still unclear. This study is aimed to evaluate the association between acne …

Animal models to improve our understanding and treatment of suicidal behavior

TD Gould, P Georgiou, LA Brenner, L Brundin… - Translational …, 2017 - nature.com
Worldwide, suicide is a leading cause of death. Although a sizable proportion of deaths by
suicide may be preventable, it is well documented that despite major governmental and …

Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database

K Sato, T Mano, A Iwata, T Toda - Bioscience trends, 2020 - jstage.jst.go.jp
In late March and early April 2020, the antimalarial drug, chloroquine, has been approved as
an emergency treatment for the coronavirus disease 2019 (COVID-19) in the United States …

[HTML][HTML] Isotretinoin and neuropsychiatric side effects: continued vigilance is needed

JD Bremner - Journal of affective disorders reports, 2021 - Elsevier
Abstract Background Isotretinoin (13-cis-retinoic acid, marketed under the names Accutane,
Roaccutane, and others) is an effective treatment for acne that has been on the market for …

Association of isotretinoin with depression and suicide: a review of current literature

JM Oliveira, G Sobreira, J Velosa… - Journal of …, 2018 - journals.sagepub.com
Acne vulgaris, a condition that can affect people at any age, is the most common cause of
referral to a dermatologist. Isotretinoin (ITT) is the most effective treatment available, but …

[HTML][HTML] Psychiatric and developmental effects of isotretinoin (retinoid) treatment for acne vulgaris

A Suuberg - Current Therapeutic Research, 2019 - Elsevier
Background An association between isotretinoin (13-cis-retinoic acid, sold under trade
names including Accutane [Hoffmann-La Roche Inc, Basel, Switzerland]) and birth defects …